放射性医薬品セラノスティクスのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Radiopharmaceutical Theranostics Market Insights, Forecast to 2028

• レポートコード：QY2207E03823 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：消費財

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の放射性医薬品セラノスティクスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に放射性医薬品セラノスティクスの世界市場のxxx％を占める「腫瘍」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の放射性医薬品セラノスティクスの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの放射性医薬品セラノスティクス市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの放射性医薬品セラノスティクス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 放射性医薬品セラノスティクスのグローバル主要メーカーには、Nihon Medi-Physics、ITM Isotopen Technologien München AG、Advanced Accelerator Applications、Telix Pharmaceuticals、GE Healthcare、Theragnostics Ltd.、NuView Life Sciences、Jubilant Pharma Limited、Lantheus Holdings, Inc.、Curium Pharma、Bayer AG、Clarity Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 放射性医薬品セラノスティクス市場は、種類と用途によって区分されます。世界の放射性医薬品セラノスティクス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 腫瘍、心臓病、その他 【用途別セグメント】 病院、学術研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 放射性医薬品セラノスティクス製品概要 - 種類別市場（腫瘍、心臓病、その他） - 用途別市場（病院、学術研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の放射性医薬品セラノスティクス販売量予測2017-2028 - 世界の放射性医薬品セラノスティクス売上予測2017-2028 - 放射性医薬品セラノスティクスの地域別販売量 - 放射性医薬品セラノスティクスの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別放射性医薬品セラノスティクス販売量 - 主要メーカー別放射性医薬品セラノスティクス売上 - 主要メーカー別放射性医薬品セラノスティクス価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（腫瘍、心臓病、その他） - 放射性医薬品セラノスティクスの種類別販売量 - 放射性医薬品セラノスティクスの種類別売上 - 放射性医薬品セラノスティクスの種類別価格 ・用途別市場規模（病院、学術研究機関、その他） - 放射性医薬品セラノスティクスの用途別販売量 - 放射性医薬品セラノスティクスの用途別売上 - 放射性医薬品セラノスティクスの用途別価格 ・北米市場 - 北米の放射性医薬品セラノスティクス市場規模（種類別、用途別） - 主要国別の放射性医薬品セラノスティクス市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの放射性医薬品セラノスティクス市場規模（種類別、用途別） - 主要国別の放射性医薬品セラノスティクス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の放射性医薬品セラノスティクス市場規模（種類別、用途別） - 主要国別の放射性医薬品セラノスティクス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の放射性医薬品セラノスティクス市場規模（種類別、用途別） - 主要国別の放射性医薬品セラノスティクス市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの放射性医薬品セラノスティクス市場規模（種類別、用途別） - 主要国別の放射性医薬品セラノスティクス市場規模（トルコ、サウジアラビア） ・企業情報 Nihon Medi-Physics、ITM Isotopen Technologien München AG、Advanced Accelerator Applications、Telix Pharmaceuticals、GE Healthcare、Theragnostics Ltd.、NuView Life Sciences、Jubilant Pharma Limited、Lantheus Holdings, Inc.、Curium Pharma、Bayer AG、Clarity Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 放射性医薬品セラノスティクスの産業チェーン分析 - 放射性医薬品セラノスティクスの原材料 - 放射性医薬品セラノスティクスの生産プロセス - 放射性医薬品セラノスティクスの販売及びマーケティング - 放射性医薬品セラノスティクスの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 放射性医薬品セラノスティクスの産業動向 - 放射性医薬品セラノスティクスのマーケットドライバー - 放射性医薬品セラノスティクスの課題 - 放射性医薬品セラノスティクスの阻害要因 ・主な調査結果

Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
Market Analysis and Insights: Global Radiopharmaceutical Theranostics Market
The global Radiopharmaceutical Theranostics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oncology accounting for % of the Radiopharmaceutical Theranostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Radiopharmaceutical Theranostics market size is valued at US$ million in 2021, while the North America and Europe Radiopharmaceutical Theranostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Radiopharmaceutical Theranostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Radiopharmaceutical Theranostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Radiopharmaceutical Theranostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Radiopharmaceutical Theranostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Radiopharmaceutical Theranostics market.
Global Radiopharmaceutical Theranostics Scope and Market Size
Radiopharmaceutical Theranostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Radiopharmaceutical Theranostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oncology
Cardiology
Others
Segment by Application
Hospitals
Academic & Research Institutes
Others
By Company
Nihon Medi-Physics
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
GE Healthcare
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Curium Pharma
Bayer AG
Clarity Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Theranostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oncology
1.2.3 Cardiology
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Theranostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Academic & Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Theranostics Market Perspective (2017-2028)
2.2 Radiopharmaceutical Theranostics Growth Trends by Region
2.2.1 Radiopharmaceutical Theranostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Radiopharmaceutical Theranostics Historic Market Size by Region (2017-2022)
2.2.3 Radiopharmaceutical Theranostics Forecasted Market Size by Region (2023-2028)
2.3 Radiopharmaceutical Theranostics Market Dynamics
2.3.1 Radiopharmaceutical Theranostics Industry Trends
2.3.2 Radiopharmaceutical Theranostics Market Drivers
2.3.3 Radiopharmaceutical Theranostics Market Challenges
2.3.4 Radiopharmaceutical Theranostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Theranostics Players by Revenue
3.1.1 Global Top Radiopharmaceutical Theranostics Players by Revenue (2017-2022)
3.1.2 Global Radiopharmaceutical Theranostics Revenue Market Share by Players (2017-2022)
3.2 Global Radiopharmaceutical Theranostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceutical Theranostics Revenue
3.4 Global Radiopharmaceutical Theranostics Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Theranostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Theranostics Revenue in 2021
3.5 Radiopharmaceutical Theranostics Key Players Head office and Area Served
3.6 Key Players Radiopharmaceutical Theranostics Product Solution and Service
3.7 Date of Enter into Radiopharmaceutical Theranostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Theranostics Breakdown Data by Type
4.1 Global Radiopharmaceutical Theranostics Historic Market Size by Type (2017-2022)
4.2 Global Radiopharmaceutical Theranostics Forecasted Market Size by Type (2023-2028)
5 Radiopharmaceutical Theranostics Breakdown Data by Application
5.1 Global Radiopharmaceutical Theranostics Historic Market Size by Application (2017-2022)
5.2 Global Radiopharmaceutical Theranostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Radiopharmaceutical Theranostics Market Size (2017-2028)
6.2 North America Radiopharmaceutical Theranostics Market Size by Type
6.2.1 North America Radiopharmaceutical Theranostics Market Size by Type (2017-2022)
6.2.2 North America Radiopharmaceutical Theranostics Market Size by Type (2023-2028)
6.2.3 North America Radiopharmaceutical Theranostics Market Share by Type (2017-2028)
6.3 North America Radiopharmaceutical Theranostics Market Size by Application
6.3.1 North America Radiopharmaceutical Theranostics Market Size by Application (2017-2022)
6.3.2 North America Radiopharmaceutical Theranostics Market Size by Application (2023-2028)
6.3.3 North America Radiopharmaceutical Theranostics Market Share by Application (2017-2028)
6.4 North America Radiopharmaceutical Theranostics Market Size by Country
6.4.1 North America Radiopharmaceutical Theranostics Market Size by Country (2017-2022)
6.4.2 North America Radiopharmaceutical Theranostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Radiopharmaceutical Theranostics Market Size (2017-2028)
7.2 Europe Radiopharmaceutical Theranostics Market Size by Type
7.2.1 Europe Radiopharmaceutical Theranostics Market Size by Type (2017-2022)
7.2.2 Europe Radiopharmaceutical Theranostics Market Size by Type (2023-2028)
7.2.3 Europe Radiopharmaceutical Theranostics Market Share by Type (2017-2028)
7.3 Europe Radiopharmaceutical Theranostics Market Size by Application
7.3.1 Europe Radiopharmaceutical Theranostics Market Size by Application (2017-2022)
7.3.2 Europe Radiopharmaceutical Theranostics Market Size by Application (2023-2028)
7.3.3 Europe Radiopharmaceutical Theranostics Market Share by Application (2017-2028)
7.4 Europe Radiopharmaceutical Theranostics Market Size by Country
7.4.1 Europe Radiopharmaceutical Theranostics Market Size by Country (2017-2022)
7.4.2 Europe Radiopharmaceutical Theranostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Theranostics Market Size (2017-2028)
8.2 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Type
8.2.1 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Radiopharmaceutical Theranostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Application
8.3.1 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Radiopharmaceutical Theranostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Region
8.4.1 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Radiopharmaceutical Theranostics Market Size (2017-2028)
9.2 Latin America Radiopharmaceutical Theranostics Market Size by Type
9.2.1 Latin America Radiopharmaceutical Theranostics Market Size by Type (2017-2022)
9.2.2 Latin America Radiopharmaceutical Theranostics Market Size by Type (2023-2028)
9.2.3 Latin America Radiopharmaceutical Theranostics Market Share by Type (2017-2028)
9.3 Latin America Radiopharmaceutical Theranostics Market Size by Application
9.3.1 Latin America Radiopharmaceutical Theranostics Market Size by Application (2017-2022)
9.3.2 Latin America Radiopharmaceutical Theranostics Market Size by Application (2023-2028)
9.3.3 Latin America Radiopharmaceutical Theranostics Market Share by Application (2017-2028)
9.4 Latin America Radiopharmaceutical Theranostics Market Size by Country
9.4.1 Latin America Radiopharmaceutical Theranostics Market Size by Country (2017-2022)
9.4.2 Latin America Radiopharmaceutical Theranostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Theranostics Market Size (2017-2028)
10.2 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Type
10.2.1 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Radiopharmaceutical Theranostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Application
10.3.1 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Radiopharmaceutical Theranostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Country
10.4.1 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Radiopharmaceutical Theranostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Nihon Medi-Physics
11.1.1 Nihon Medi-Physics Company Details
11.1.2 Nihon Medi-Physics Business Overview
11.1.3 Nihon Medi-Physics Radiopharmaceutical Theranostics Introduction
11.1.4 Nihon Medi-Physics Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.1.5 Nihon Medi-Physics Recent Developments
11.2 ITM Isotopen Technologien München AG
11.2.1 ITM Isotopen Technologien München AG Company Details
11.2.2 ITM Isotopen Technologien München AG Business Overview
11.2.3 ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics Introduction
11.2.4 ITM Isotopen Technologien München AG Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.2.5 ITM Isotopen Technologien München AG Recent Developments
11.3 Advanced Accelerator Applications
11.3.1 Advanced Accelerator Applications Company Details
11.3.2 Advanced Accelerator Applications Business Overview
11.3.3 Advanced Accelerator Applications Radiopharmaceutical Theranostics Introduction
11.3.4 Advanced Accelerator Applications Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.3.5 Advanced Accelerator Applications Recent Developments
11.4 Telix Pharmaceuticals
11.4.1 Telix Pharmaceuticals Company Details
11.4.2 Telix Pharmaceuticals Business Overview
11.4.3 Telix Pharmaceuticals Radiopharmaceutical Theranostics Introduction
11.4.4 Telix Pharmaceuticals Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.4.5 Telix Pharmaceuticals Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Radiopharmaceutical Theranostics Introduction
11.5.4 GE Healthcare Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.5.5 GE Healthcare Recent Developments
11.6 Theragnostics Ltd.
11.6.1 Theragnostics Ltd. Company Details
11.6.2 Theragnostics Ltd. Business Overview
11.6.3 Theragnostics Ltd. Radiopharmaceutical Theranostics Introduction
11.6.4 Theragnostics Ltd. Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.6.5 Theragnostics Ltd. Recent Developments
11.7 NuView Life Sciences
11.7.1 NuView Life Sciences Company Details
11.7.2 NuView Life Sciences Business Overview
11.7.3 NuView Life Sciences Radiopharmaceutical Theranostics Introduction
11.7.4 NuView Life Sciences Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.7.5 NuView Life Sciences Recent Developments
11.8 Jubilant Pharma Limited
11.8.1 Jubilant Pharma Limited Company Details
11.8.2 Jubilant Pharma Limited Business Overview
11.8.3 Jubilant Pharma Limited Radiopharmaceutical Theranostics Introduction
11.8.4 Jubilant Pharma Limited Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.8.5 Jubilant Pharma Limited Recent Developments
11.9 Lantheus Holdings, Inc.
11.9.1 Lantheus Holdings, Inc. Company Details
11.9.2 Lantheus Holdings, Inc. Business Overview
11.9.3 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Introduction
11.9.4 Lantheus Holdings, Inc. Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.9.5 Lantheus Holdings, Inc. Recent Developments
11.10 Curium Pharma
11.10.1 Curium Pharma Company Details
11.10.2 Curium Pharma Business Overview
11.10.3 Curium Pharma Radiopharmaceutical Theranostics Introduction
11.10.4 Curium Pharma Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.10.5 Curium Pharma Recent Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Radiopharmaceutical Theranostics Introduction
11.11.4 Bayer AG Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.11.5 Bayer AG Recent Developments
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Details
11.12.2 Clarity Pharmaceuticals Business Overview
11.12.3 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Introduction
11.12.4 Clarity Pharmaceuticals Revenue in Radiopharmaceutical Theranostics Business (2017-2022)
11.12.5 Clarity Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Radiopharmaceutical Theranostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oncology
Table 3. Key Players of Cardiology
Table 4. Key Players of Others
Table 5. Global Radiopharmaceutical Theranostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Radiopharmaceutical Theranostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Radiopharmaceutical Theranostics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Radiopharmaceutical Theranostics Market Share by Region (2017-2022)
Table 9. Global Radiopharmaceutical Theranostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Radiopharmaceutical Theranostics Market Share by Region (2023-2028)
Table 11. Radiopharmaceutical Theranostics Market Trends
Table 12. Radiopharmaceutical Theranostics Market Drivers
Table 13. Radiopharmaceutical Theranostics Market Challenges
Table 14. Radiopharmaceutical Theranostics Market Restraints
Table 15. Global Radiopharmaceutical Theranostics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Radiopharmaceutical Theranostics Revenue Share by Players (2017-2022)
Table 17. Global Top Radiopharmaceutical Theranostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Theranostics as of 2021)
Table 18. Ranking of Global Top Radiopharmaceutical Theranostics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Radiopharmaceutical Theranostics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Radiopharmaceutical Theranostics Product Solution and Service
Table 22. Date of Enter into Radiopharmaceutical Theranostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Radiopharmaceutical Theranostics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Radiopharmaceutical Theranostics Revenue Market Share by Type (2017-2022)
Table 26. Global Radiopharmaceutical Theranostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Radiopharmaceutical Theranostics Revenue Market Share by Type (2023-2028)
Table 28. Global Radiopharmaceutical Theranostics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Radiopharmaceutical Theranostics Revenue Share by Application (2017-2022)
Table 30. Global Radiopharmaceutical Theranostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Radiopharmaceutical Theranostics Revenue Share by Application (2023-2028)
Table 32. North America Radiopharmaceutical Theranostics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Radiopharmaceutical Theranostics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Radiopharmaceutical Theranostics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Radiopharmaceutical Theranostics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Radiopharmaceutical Theranostics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Radiopharmaceutical Theranostics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Radiopharmaceutical Theranostics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Radiopharmaceutical Theranostics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Radiopharmaceutical Theranostics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Radiopharmaceutical Theranostics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Radiopharmaceutical Theranostics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Radiopharmaceutical Theranostics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Radiopharmaceutical Theranostics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Radiopharmaceutical Theranostics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Radiopharmaceutical Theranostics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Radiopharmaceutical Theranostics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Radiopharmaceutical Theranostics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Radiopharmaceutical Theranostics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Radiopharmaceutical Theranostics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Radiopharmaceutical Theranostics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Radiopharmaceutical Theranostics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Radiopharmaceutical Theranostics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Radiopharmaceutical Theranostics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Radiopharmaceutical Theranostics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Nihon Medi-Physics Company Details
Table 63. Nihon Medi-Physics Business Overview
Table 64. Nihon Medi-Physics Radiopharmaceutical Theranostics Product
Table 65. Nihon Medi-Physics Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 66. Nihon Medi-Physics Recent Developments
Table 67. ITM Isotopen Technologien München AG Company Details
Table 68. ITM Isotopen Technologien München AG Business Overview
Table 69. ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics Product
Table 70. ITM Isotopen Technologien München AG Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 71. ITM Isotopen Technologien München AG Recent Developments
Table 72. Advanced Accelerator Applications Company Details
Table 73. Advanced Accelerator Applications Business Overview
Table 74. Advanced Accelerator Applications Radiopharmaceutical Theranostics Product
Table 75. Advanced Accelerator Applications Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 76. Advanced Accelerator Applications Recent Developments
Table 77. Telix Pharmaceuticals Company Details
Table 78. Telix Pharmaceuticals Business Overview
Table 79. Telix Pharmaceuticals Radiopharmaceutical Theranostics Product
Table 80. Telix Pharmaceuticals Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 81. Telix Pharmaceuticals Recent Developments
Table 82. GE Healthcare Company Details
Table 83. GE Healthcare Business Overview
Table 84. GE Healthcare Radiopharmaceutical Theranostics Product
Table 85. GE Healthcare Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 86. GE Healthcare Recent Developments
Table 87. Theragnostics Ltd. Company Details
Table 88. Theragnostics Ltd. Business Overview
Table 89. Theragnostics Ltd. Radiopharmaceutical Theranostics Product
Table 90. Theragnostics Ltd. Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 91. Theragnostics Ltd. Recent Developments
Table 92. NuView Life Sciences Company Details
Table 93. NuView Life Sciences Business Overview
Table 94. NuView Life Sciences Radiopharmaceutical Theranostics Product
Table 95. NuView Life Sciences Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 96. NuView Life Sciences Recent Developments
Table 97. Jubilant Pharma Limited Company Details
Table 98. Jubilant Pharma Limited Business Overview
Table 99. Jubilant Pharma Limited Radiopharmaceutical Theranostics Product
Table 100. Jubilant Pharma Limited Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 101. Jubilant Pharma Limited Recent Developments
Table 102. Lantheus Holdings, Inc. Company Details
Table 103. Lantheus Holdings, Inc. Business Overview
Table 104. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Product
Table 105. Lantheus Holdings, Inc. Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 106. Lantheus Holdings, Inc. Recent Developments
Table 107. Curium Pharma Company Details
Table 108. Curium Pharma Business Overview
Table 109. Curium Pharma Radiopharmaceutical Theranostics Product
Table 110. Curium Pharma Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 111. Curium Pharma Recent Developments
Table 112. Bayer AG Company Details
Table 113. Bayer AG Business Overview
Table 114. Bayer AG Radiopharmaceutical Theranostics Product
Table 115. Bayer AG Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 116. Bayer AG Recent Developments
Table 117. Clarity Pharmaceuticals Company Details
Table 118. Clarity Pharmaceuticals Business Overview
Table 119. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product
Table 120. Clarity Pharmaceuticals Revenue in Radiopharmaceutical Theranostics Business (2017-2022) & (US$ Million)
Table 121. Clarity Pharmaceuticals Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiopharmaceutical Theranostics Market Share by Type: 2021 VS 2028
Figure 2. Oncology Features
Figure 3. Cardiology Features
Figure 4. Others Features
Figure 5. Global Radiopharmaceutical Theranostics Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Academic & Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Radiopharmaceutical Theranostics Report Years Considered
Figure 10. Global Radiopharmaceutical Theranostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Radiopharmaceutical Theranostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Radiopharmaceutical Theranostics Market Share by Region: 2021 VS 2028
Figure 13. Global Radiopharmaceutical Theranostics Market Share by Players in 2021
Figure 14. Global Top Radiopharmaceutical Theranostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Theranostics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Radiopharmaceutical Theranostics Revenue in 2021
Figure 16. North America Radiopharmaceutical Theranostics Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Radiopharmaceutical Theranostics Market Size Market Share by Type (2017-2028)
Figure 18. North America Radiopharmaceutical Theranostics Market Size Market Share by Application (2017-2028)
Figure 19. North America Radiopharmaceutical Theranostics Market Size Share by Country (2017-2028)
Figure 20. United States Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Radiopharmaceutical Theranostics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Radiopharmaceutical Theranostics Market Size Market Share by Type (2017-2028)
Figure 24. Europe Radiopharmaceutical Theranostics Market Size Market Share by Application (2017-2028)
Figure 25. Europe Radiopharmaceutical Theranostics Market Size Share by Country (2017-2028)
Figure 26. Germany Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Radiopharmaceutical Theranostics Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Radiopharmaceutical Theranostics Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Radiopharmaceutical Theranostics Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Radiopharmaceutical Theranostics Market Size Share by Region (2017-2028)
Figure 36. China Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Radiopharmaceutical Theranostics Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Radiopharmaceutical Theranostics Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Radiopharmaceutical Theranostics Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Radiopharmaceutical Theranostics Market Size Share by Country (2017-2028)
Figure 46. Mexico Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Radiopharmaceutical Theranostics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Radiopharmaceutical Theranostics Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Radiopharmaceutical Theranostics Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Radiopharmaceutical Theranostics Market Size Share by Country (2017-2028)
Figure 52. Turkey Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Radiopharmaceutical Theranostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Nihon Medi-Physics Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 56. ITM Isotopen Technologien München AG Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 57. Advanced Accelerator Applications Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 58. Telix Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 59. GE Healthcare Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 60. Theragnostics Ltd. Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 61. NuView Life Sciences Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 62. Jubilant Pharma Limited Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 63. Lantheus Holdings, Inc. Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 64. Curium Pharma Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 65. Bayer AG Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 66. Clarity Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Theranostics Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---